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Migration of Anterior Visceral Endoderm (AVE) is a critical symmetry breaking event in the early post-
implantation embryo development and is essential for establishing the correct body plan. Despite much effort,
cellular and molecular events inﬂuencing AVE migration are only partially understood. Here, using time-lapse live
imaging of mouse embryos, we demonstrate that cell division in the embryonic visceral endoderm is coordinated
with AVE migration. Moreover, we demonstrate that temporal inhibition of FGF signalling during the pre-
implantation speciﬁcation of embryonic visceral endoderm perturbs cell cycle progression, thus affecting AVE
migration. These ﬁndings demonstrate that coordinated cell cycle progression during the implantation stages of
development is important for post-implantation morphogenesis in the mouse embryo.1. Introduction
The transition from pre-to post-implantation in mouse embryogenesis
is marked by remarkable morphological changes; the round implanting
blastocyst is transformed into an elongated egg cylinder with an Anterior-
Posterior (AP) axis. During implantation, the polar trophectoderm of the
blastocyst transforms into the extra-embryonic ectoderm (ExE) which
signals posterior development to the epiblast (EPI). The primitive
endoderm (PE) of the blastocyst differentiates into parietal endoderm
and the visceral endoderm (VE), which constitutes the outer epithelial
layer that surrounds the ExE and EPI. By embryonic day (E)5.5, a Nodal
gradient becomes established in the EPI leading to the emergence of the
proximal-distal axis (Arnold and Robertson, 2009). This signalling is
distally inhibited by the Nodal antagonists Lefty1 and Cerberus (Cerl),
secreted by a specialised subpopulation of embryonic VE cells known as
the distal visceral endoderm (DVE) (Belo et al., 1997; Yamamoto et al.,
2004). A few hours after their speciﬁcation, DVE cells acquire a migra-
tory morphology and together with the newly formed AVE (Takaoka
et al., 2011; Morris et al., 2012) move unilaterally towards the
embryonic/extra-embryonic (Em/Ex) boundary (Srinivas et al., 2004),
the future anterior side of the embryo. The localization of AVE on one-Goetz).
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streak will form on the posterior side (Brennan et al., 2001). The cellular
mechanisms that play a role in the asymmetric positioning of the AVE are
not well understood (Stower and Srinivas, 2014). Previous studies have
revealed that AVE cells actively migrate and change their shape through
remodelling of the cytoskeleton, which results in cell intercalation
(Migeotte et al., 2010; Morris et al., 2012; Omelchenko et al., 2014;
Srinivas et al., 2004; Stower and Srinivas, 2014; Trichas et al., 2012).
However, how AVE migration relates to cell cycle progression in the VE
has been a matter of debate (Stuckey et al., 2011a; Yamamoto et al.,
2004). Indeed, Stuckey and colleagues did not observe any difference in
the frequency of mitoses within VE by analysing ﬁxed samples stained for
mitotic markers. They also proposed that cell proliferation in the EPI and
its subsequent growth and expansion lead to the migration of AVE
(Stuckey et al., 2011a). By contrast, Yamamoto and colleagues proposed
that AVE migration could be driven by differential proliferation within
the VE resulting from asymmetry in Nodal signalling (Yamamoto et al.,
2004). Both studies were based on analyses of ﬁxed samples and none
have analysed the dynamics of cell divisions during AVE migration and
whether there is any spatio-temporal coordination between the two
events. To address this, we use time-lapse imaging of visceral endodermpartment of Cellular, Computational and Integrative Biology – CIBIO, University
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coordinated with progression through the cell cycle. Moreover, our re-
sults suggest that coordinated cell cycle progression originates from
signalling events in pre-implantation development.
2. Results
2.1. Spatio-temporal correlation between AVE migration and coordinated
cell division
As AVE migration commences around E5.5, we focused on analysing
the dynamics of cell cycle progression around this time. In order to relate
cell cycle progression to AVE migration, we ﬁrst generated double
transgenic embryos for the AVE marker Cerl (Cerl-GFP) (Mesnard et al.,
2004) and the cell cycle reporter R26Fucci2a (Fluorescent
Ubiquitination-based Cell Cycle Indicator) (Mort et al., 2014) (Fig. 1A).
The bicistronic Fucci2a construct encodes truncated versions of the Cdt1
and Geminin proteins that are degraded reciprocally during cell cycle
progression; mCherry-hCdt1(30/120) levels peak in G1, and
mVenus-hGem(1/110) levels peak in S/G2/M phases. Fucci2a thus al-
lows assessment of cell cycle progression using live imaging (Mort et al.,
2014) (Fig. 1A). Wewere able to distinguish GFP andmVenus signals and
thereby identify Cerl-expressing cells and cells in S/G2/M (Fig. S1A). We
assessed cell cycle progression approximately 12 h and 24 h after im-
plantation by recovering embryos at E5.0 and E5.5, respectively.
R26Fucci2a/CerI-GFP or R26Fucci2a embryos recovered at E5.5 or E5.0
respectively and imaged with multi-photon confocal microscopy both
showed mVenus-expressing cells (in S/G2/M phase) (Fig. 1B, upper and
middle panels; Fig. 2E). However, we could not detect mCherry labelled
cells, most likely due to the short G1 phase characteristic of early
post-implantation development, a similar ﬁnding to one described for
mouse embryonic stem cells (Mort et al., 2014). Indeed, we were only
able to detect a few positive mCherry labelled cells in the distal part of
late E6.5 embryos when we applied higher laser power, incompatible
with live imaging experiments (Fig. S1B). This is in line with previous
ﬁndings that it is rare to detect G1 cells in Fucci embryos between E5.5
and E6.5 (Abe et al., 2013).
To enable comparisons between embryos, we determined the number
of mVenusþ cells in posterior and anterior embryonic parts of VE (emVE)
of E5.5 embryos over time (Figs. S1C–E) and normalised temporal pro-
gression relative to the time point with the highest number of mVenusþ
cells. This revealed that within 4 h there was a 36.5% (n¼ 5) decrease in
the number of mVenusþ cells in the entire emVE indicative of a coordi-
nated burst of cell division (Fig. 1C, upper graph). When we analysed
anterior and posterior emVE separately (Fig. 1C middle and lower
graphs), the decrease in the number of mVenusþ cells appeared more
striking in the posterior than in the anterior part of the embryo (49.9% vs
19.6% respectively, n¼ 5) suggesting an element of coordinated cell
division in the posterior emVE in a speciﬁc time window.We also found a
3-fold difference between the rate of decrease of mVenusþ cells in the
anterior versus the posterior (Fig. 1D). We measured AVE migration by
measuring the distance between the leading CerI-GFPþ migratory cell
and the distal tip (Fig. 1A) over the same interval (Fig. 1E and Fig. S1F;
method for alignment of maximal value indicated in Fig. S1F). We found
that the AVE migration speed was signiﬁcantly higher after cells divided
in posterior (2.2 μm/h 0.7 μm/h before the peak of mVenusþ cells;
5.7 μm/h 1.3 μm/h after the peak) (Fig. 1F). These results indicate a
spatio-temporal correlation between the timing of AVE migration and
cell division in emVE suggesting that coordinated cell cycle progression
may contribute to drive AVE migration.
To directly address whether AVE migration is dependent on coordi-
nated cell cycle progression, we recovered Cerl-GFP embryos from
mothers prior to AVE speciﬁcation at E5.25-E5.5 and cultured them in
the presence of the reversible Cyclin-Dependent Kinase 1 inhibitor, RO-
3306, that arrests cells at G2/M (Jang et al., 2014; Vassilev et al.,
2006). We chose to use a Cyclin-Dependent Kinase 1 inhibitor to arrest133cells at G2/M instead of a microtubule depolymerising agent, such as
Nocodazole, because of the known requirement for microtubules for cell
migration (Baudoin et al., 2008). Following 8 h of RO-3306 treatment,
we observed a reduction in the number of Gata4 positive emVE and Oct4
positive epiblast cells (Fig. S2 A-C) conﬁrming the efﬁcacy of the drug.
Afterwards, we washed out the inhibitor and performed a 12 h live im-
aging (Fig. 2A). We veriﬁed that there was no difference in size between
control and RO-3306 treated embryos at the end of the experiment
(Figs. S2D–E) suggesting the growth of the embryos was not affected after
treatment with the drug. We also found that AVE migration was strongly
reduced following RO-3306 treatment (Fig. 2B). Indeed, 85.7% of treated
embryos showed abnormal migration in which the Cerl-GFP expressing
cells remained in a predominantly distal position (Fig. 2C).
To ask whether the coordinated cell divisions may already take place
before AVE speciﬁcation occurs, we carried out live imaging of early
post-implantation E5.0 R26Fucci2a embryos (Fig. 2D–E) and analysed
the number of mVenusþ cells (Fig. S2F). We observed periodic ﬂuctua-
tions in the number of mVenusþ cells (Fig. 2F) and, similar to E5.5
R26Fucci2a/CerI-GFP embryos (Fig. 1C), the fall in the number of
mVenusþ cells took place over approximately 4 h, suggesting coordinated
cell division took place in the emVE immediately following implantation.
Together, these results suggest that coordinated cell division contributes
to the migration of the AVE during early post-implantation development.2.2. Perturbation of FGF signalling during PE speciﬁcation affects cell cycle
progression in post-implanting embryos
We next wished to identify at which point in development cell cycle
control might be imposed upon the developing emVE. We therefore
asked whether this might begin already before implantation when the PE
is ﬁrst speciﬁed in response to ﬁbroblast growth factor (FGF) signalling
(Kang et al., 2017; Molotkov et al., 2017; Morris et al., 2013; Yamanaka
et al., 2010). This seemed possible because FGF has also been proposed to
act as a mitogen (Ornitz and Itoh, 2015; Turner and Grose, 2010). As
growth factor stimulation generally drives cells from a quiescent phase
into S phase, we determined the effect of modulating FGF signalling
during PE speciﬁcation by treating E3.5 embryos with the FGFR inhibitor
SU5402 for 5 h and assessing S-phase entry by following 5-ethy-
nyl-2’-deoxyuridine (EdU) incorporation (Salic andMitchison, 2008) and
mitosis by Phospho-Histone 3 (pH3) immunostaining, using Sox17 as a
primitive endoderm marker (Fig. 3A). Before the treatment, the majority
of Sox17þ cells were in S-phase (83.23%) and no mitoses were detected
in the newly speciﬁed PE (Fig. 3B). After 5 h, control embryos showed a
burst of mitoses in around 9.3% of Sox17þ cells and this was reduced to
2.1% following FGF inhibition by the 5 h treatment with SU5402
(Fig. 3C). Nevertheless, in contrast to a longer treatment with FGFR or
MEK inhibitors (Krawchuk et al., 2013; Yamanaka et al., 2010), this 5 h
pulse of SU5402 did not affect lineage allocation following a 19 h re-
covery period (Fig. 3D–E).
To address the potential effects of the 5 h SU5402 treatment upon
development of the VE, we treated E3.5 R26Fucci2a embryos with
SU5402 for 5 h, transferred them to foster mothers and subsequently
recovered them at E5.5 for analysis by live imaging (Fig. 3F). Both groups
of embryos were indistinguishable in size (Figs. S3A–B) indicating that
the pre-implantation treatment and subsequent embryo transfer did not
lead to differential growth. We then counted the number of mVenusþ
cells over time in control and SU5402-treated embryos (Figs. S3C–D)
focussing on the 4 h interval we had earlier deﬁned in which the numbers
of mVenusþ cells dramatically decreased corresponding with the time of
AVE migration (Fig. 3G–H). Although all embryos showed a decreased
number of mVenusþ cells, the SU5402-treated embryos showed much
higher variability in this rate of decrease (Fig. 3I). These results indicate
that short perturbation of FGF signalling affects cell cycle progression
during PE speciﬁcation and has a subsequent impact on the spatio-
temporal coordination of cell division at post-implantation stages.
(caption on next page)
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Fig. 1. Concerted cell divisions occur during AVE migration (A) Schematic view of the experimental design: double transgenic R26Fucci2a/CerI-GFP E5.5 em-
bryos were recovered and live imaged. The R26Fucci2a cell cycle reporter was used to identify cells in S/G2/M phase (labelled with mVenus-hGem(301/120) and
termed mVenusþ cells) and AVE migration was evaluated as distance between leading CerI-GFPþ cell and distal tip of the embryo over time. (B) Anterior and posterior
view (upper and middle panels) of R26Fucci2a (mVenus signal is shown as multi-coloured LUT Fire) in VE and migrating AVE cells (bottom panel). Extra-Embryonic/
Embryonic boundary is shown as dotted line. (C) mVenusþ cells in total (upper panel), anterior (middle panel) and posterior (bottom panel) embryonic VE. Number of
cells are shown in individual embryos (thin coloured lines) or as mean (thick black line). For comparing all the embryos (raw values are shown in Figs. S1C–E) we
considered time 0 h as the time point before the peak (1 h) of mVenusþ cells shown in total emVE (bottom panel). (D) Decrease of mVenusþ cells per h in the anterior
or posterior emVE during time interval 1 h–5 h. Data are shown as mean sem (Unpaired t-test, *p¼ 0.03). (E) AVE migration shown as distance between leading CerI-
GFPþ cell and distal tip of the embryo over time (1 h time interval). Values are shown in individual embryos (thin coloured lines) or as mean (thick black line). For
comparing all the embryos (raw values are shown in Fig. S1F) we considered time 0 h as the time point before the peak (1 h) of mVenusþ cells shown in total emVE. (F)
AVE migration speed shown as μm/h before and after the peak of mVenusþ cells. Data are shown as mean sem (Unpaired t-test, *p¼ 0.03).
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implantation morphogenesis
In the light of these results, we asked whether perturbing FGF sig-
nalling already at the blastocyst stage would affect AVE migration. To
this end, we treated Cerl-GFP E3.5 embryos for 5 h with SU5402, trans-
ferred them to foster mothers and recovered them at E5.5 and assessed
the directionality and speed of AVE migration (Fig. 4A). As expected, in
100% of control embryos, AVE cells migrated unidirectionally from the
distal tip towards the ExE/EPI boundary (Fig. 4B, n¼ 4). However,
amongst the SU5402-treated embryos only 63.6% (n¼ 11) of embryos
displayed unilateral migration similar to controls (SU5402-treated - Class
I; Fig. 4C). By contrast, the remaining 36.4% embryos (SU5402-treated -
Class II) showed aberrant migration, with AVE cells not fully reaching the
Em/Ex boundary (Fig. 4D). Despite the different phenotype between
control and SU5402-treated embryos, there was no difference in their
size at the time of the recovery (Figs. S4A–B). In addition, all groups
exhibited formation of ﬁlopodia indicating that the short treatment with
FGFR inhibitor performed 3 days earlier did not affect the active cell
migration machinery (Fig. 4D). Despite the apparent unaffected migra-
tion path, we investigated whether SU5402 - class I showed any differ-
ence in AVE migration speed. To this end, we assessed AVE migration by
measuring the distance between the leading CerI-GFPþ migratory cell
and the distal tip over time (Figs. S4C–D). We found that whereas the
AVE of control embryos displayed a migration speed of 5.4 μm/h 
0.5 μm/h, the AVE of SU5402-treated - Class I embryos migrated slightly
faster (6.3 μm/h 1.1 μm/h) and with a higher variability (Fig. 4F).
When we considered the AVE migration speed of individual SU5402-
treated - Class I embryos, we observed that 5/7 resided outside of the
control interdecile range (ID range shown in grey) (Fig. 4F). Interest-
ingly, despite unidirectional migration of AVE, SU5402-treated - Class I
embryos displayed signiﬁcant alterations in AVE migration, which, taken
together with the aberrant AVE migration in SU5402-treated – Class II
embryos, indicate that 81.8% of the embryos had abnormal AVE
migration (Fig. 4G).
Given that inhibition of FGF signalling during pre-implantation
resulted in abnormal AVE migration, we next asked whether cell fate,
AP patterning and later post-implantation development were also
affected. We found that at E6.5, SU5402-treated embryos stained for
Brachyury, an early mesodermal lineage marker expressed in the prim-
itive streak, were indistinguishable from control embryos (Figs. S4E–F)
with both groups showing unilateral formation of the primitive streak in
all embryos (n¼ 4 control and n¼ 6 SU5402-treated embryos). In addi-
tion, both groups showed formation of basement membrane (Fig. S4F,
bottom panels) that is known to be directly controlled by FGF (Costello
et al., 2009). This suggests that treatment with SU5402 acted speciﬁcally
on cell cycle/AVE migration.
Together our ﬁndings demonstrate that the migration of AVE cells is
coordinated with and dependent upon the progression of VE cells
through the cell division cycle.
3. Discussion
Mouse embryos undergo morphogenetic remodelling at the time of135implantation during which the VE shapes the AP patterning of the EPI
(Brennan et al., 2001). This process is mediated by a specialised popu-
lation of VE cells, which following their speciﬁcation at the distal tip of
the embryo, migrate towards the future anterior side (Morris et al.,
2012). This is a highly coordinated process requiring AVE cells to actively
migrate (Migeotte et al., 2010; Morris et al., 2012; Omelchenko et al.,
2014; Srinivas et al., 2004) as the entire emVE undergoes rearrangement
in cell shape (Stower and Srinivas, 2014) whereas cell proliferation leads
the embryo to increase in size. We sought to address whether coordinated
progression through the cell cycle is required for AVE migration. To gain
spatio-temporal resolution of cell division, we carried out live imaging.
This revealed that cell divisions are coordinated in the emVE compart-
ment during and before AVE migration and that AVE migration drasti-
cally increases in speed as cells divide. Moreover, we ﬁnd that proper
migration of AVE is impaired when cell cycle progression is transiently
perturbed. In embryos exposed to the G2/M reversible inhibitor
RO-3306, the AVE failed to migrate correctly even after release into fresh
medium. It has previously been proposed that AVE migration could be
driven by differential proliferation within emVE resulting from asym-
metry in Nodal signalling (Yamamoto et al., 2004). In contrast, more
recent reports failed to detect signiﬁcant differences in proliferation
amongst different regions of the emVE (Shioi et al., 2017; Stuckey et al.,
2011a). However, these studies did not analyse the dynamics of mitoses
in the emVE at the time of AVE migration. Here by using transgenic lines
reporting both the AVE and speciﬁc cell cycle stages, we have been able
to show that cell migration speed changes following a coordinated wave
of cell divisions in the posterior side of the embryo, opposite to the site of
AVE migration. We speculate that bursts of cell division, in concert with
the complex remodelling of the whole emVE due to cell intercalation
driven by PCP signalling (Trichas et al., 2012), generates sufﬁcient force
to enable the AVE to migrate.
Our live imaging of peri-implantation embryos also revealed that
coordinated cell divisions are already present in the VE shortly after the
embryo implants. While our results clearly demonstrate that coordinated
mitoses are required for the correct migration of the AVE, the cellular
underpinnings of this phenomenon remain to be fully characterised.
Since we observed coordinated mitotic events ex vivo shortly after im-
plantation it is tempting to speculate that regulated cell divisions have
their origins before implantation at the time of PE speciﬁcation. This
hypothesis is strengthened by the observation that a short perturbation of
FGF signalling does not affect lineage commitment but does alter cell
cycle progression in PE cells following transfer to foster mothers.
In addition to its role in the EPI/PE fate decision (Kang et al., 2017;
Molotkov et al., 2017; Morris et al., 2013; Yamanaka et al., 2010), the
FGF signalling pathway has been described to regulate cell proliferation
or cell cycle arrest in a context-dependent manner (Ornitz and Itoh, 2015;
Turner and Grose, 2010). FGF has been shown to act via both FGFR1 and
FGFR2 (Kang et al., 2017; Molotkov et al., 2017) and hypothesised to
control proliferation and survival of the PE (Molotkov et al., 2017). Our
ﬁndings of a decrease in the number of mitotic PE cells after FGFRs in-
hibition are in agreement with a proliferative role of FGF signalling
during pre-implantation development (Fig. 3C). The impact of FGFR in-
hibition on cell cycle progression was also observed when embryos were
transferred back to the mother and recovered at E5.5 (Fig. 3G–I).
Fig. 2. Coordinated cell divisions are set already at implantation and required during AVE migration. (A) Schematic view of the experimental design: Cerl-GFP
embryos were recovered at E5.25-E5.5 prior AVE migration, cultured in IVC2 medium supplemented with the reversible G2/M inhibitor RO-3306 for 8 h then live-
imaged after drug withdrawal. (B) Migrated AVE in control or RO3306-treated embryos 12 h after drug withdrawal. (C) Percentage of embryos showing normal or
abnormal AVE migration in control (n¼ 5) or RO3306-treated (n¼ 5) embryos 12 h after drug withdrawal. Embryos were categorised as normal when AVE migrated
until Em/Ex boundary. Otherwise considered abnormal (χ2 test, **p¼ 0.0098). (D) Schematic view of the experimental design: R26Fucci2a embryos were recovered at
E5.0 and live imaged. (E) Snapshots of an imaged E5.0 R26Fucci2a (mVenus signal shown as multi-coloured LUT Fire). (F) mVenusþ cells in embryonic VE. Number of
cells are shown in individual embryos (thin coloured lines) or as mean (thick black line). For comparing all the embryos (raw values are shown in Fig. S2C) we
considered time 0 h as the time point before the peak (1 h) of mVenusþ cells shown in total emVE.
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(Fig. 4F) and direction of AVE migration (Fig. 4B–D), even though
CerI-GFPþ cells had a morphology typical of cells able to be actively
involved in migration (Fig. 4E).
Given the limitations of working with the mouse embryo system, it is
difﬁcult to pinpoint the exact mechanisms underpinning cell cycle co-
ordination in PE precursors. One possibility is that cell-to-cell136communication may be involved. Cell-to-cell communication plays an
important role in variety of biological phenomena, including cell
migration and lineage speciﬁcation. In mouse development, communi-
cation between PE and EPI progenitors determines their speciﬁcation and
relies on FGF signalling (Kang et al., 2017; Molotkov et al., 2017). We
surmise that the progeny of PE cells is able to maintain previously ac-
quired coordination in cell cycle during their differentiation into AVE.
Fig. 3. Perturbation of FGF signalling during PE speciﬁcation affects cell cycle (A) Schematic view of the experimental design: embryos were recovered at E3.5
and treated with SU5402 for 5 h and then released in KSOM medium without the drug. EdU labelling and immunostaining for pH3 for assaying cell cycle was
performed at 0 h and 5 h while lineage analysis was performed at 24 h. (B) Distribution of G1 and S phases within SOX17þ cells at 0 h (n¼ 251 cells; 54 embryos). (C)
Distribution of G1þS and M phases within SOX17þ cells for control (n¼ 246; 34 embryos) or SU5402-treated embryos (n¼ 96; 24 embryos) (χ2 test, *p¼ 0.0204). (D)
Histograms show the number of Epiblast (Nanogþ) and PE (Gata4þ) cells in control or SU5402-treated embryos (control n¼ 13, SU5402 n¼ 9). Unpaired t-test, ns
(Epiblast) or ns (PE). (E) Histograms show the ratio PE/EPI. Unpaired t-test, ns. (F) Schematic view of the experimental design: E3.5 R26Fucci2a embryos were treated
with SU5402 for 5 h and then transferred to foster mothers. Embryos were recovered at E5.5 and live imaged. (G–H) Plot of mVenusþ cells in emVE of control (G) or
SU5402-treated (H) embryos in the 4 h following the highest number of cells shown in Figs. S3C–D. Number of mVenusþ cells are shown in individual embryos (each
colour refers to an embryo and the same colour code is used in panel I). (I) Decrease of mVenusþ cells per h in control or SU5402-treated embryos. Data are shown as
mean sd and the grey band represents the interdecile range (ID) calculated on the control values: 10% Percentile¼ 2.25and 90% Percentile¼ 3.
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AVE migration, possibly in a cell cycle independent fashion. It has been
recently shown that exchange of information between cells via molecular
diffusion and transport processes helps guide their concerted movement
in the presence of external chemical cues during mammary gland
development (Ellison et al., 2016). Since regionalisation of AVE cells to
the anterior side of mouse embryos relies on a gradient of Nodal sig-
nalling (Yamamoto et al., 2004), it is possible that a similar mechanism
could also be at play during AVE migration in mouse embryos. However,
it is unclear whether the contribution of intercellular interactions may be
accompanied by or mediated by changes in cell cycle in migrating cells.
The AVE has a pivotal role in the positioning of primitive streak
(Stuckey et al., 2011b). Indeed, genetic mutations in signalling pathways
or apical cell polarity affecting AVEmigration display defects in primitive
streak positioning or expansion (Stower and Srinivas, 2014). In this137study, we report that short pharmacological perturbation of FGF signal-
ling by disrupting cell cycle coordination in the VE selectively impairs
AVE migration but does not affect cell fate or primitive streak formation.
This discrepancy could be explained by the fact that following SU5402
treatment, despite their aberrant migration, AVE cells primarily resided
on the anterior side of the embryo, thus enabling correct positioning of
the primitive streak. Moreover, as we observed formation of primitive
streak and basement membrane deposition in SU5402 treated embryos
(Fig. S4F), the signalling pathways involved in these processes, such as
FGF, Nodal, Wnt and TGFb (Costello et al., 2009; Tam and Behringer,
1997), were most likely unaffected by transient FGF inhibition. There-
fore, we postulate that the long-term consequences of SU5402 treatment
may be cell-cycle speciﬁc. In addition to its effect on cell division, we
cannot exclude that inhibition of FGF signalling may affect cell migration
directly, as FGFs have been previously shown to act as chemoattractant
Fig. 4. FGF signalling-mediated perturbation of cell cycle affects post-implantation morphogenesis (A) Schematic view of the experimental design: E3.5 Cerl-
GFP embryos were treated with SU5402 for 5 h and then transferred to foster mothers. Embryos were recovered at E5.5 and live imaged. (B–D) Anterior view (top
panels) and lateral view (bottom panels) of migrated AVE in Cerl-GFP embryos. Embryos were divided based on the phenotype in control (B) and SU5402 treated
embryos class I (SU - class I) (C) or class II (SU - class II). (D) (Scale bar¼ 50 μm). (E) Filopodia in migrating CerI-GFPþ cells showed in control (left panel) and SU5402
treated embryos class I (middle panel) or class II (left panel). Arrows indicate ﬁlopodia. (Scale bar¼ 50 μm). (F) AVE migration speed shown as μm/h in control or SU –
class I embryos. Data are shown as mean sd (Unpaired t-test, ns). The grey band represents the interdecile range (ID) calculated on the control values: 10%
Percentile¼ 4.6 and 90% Percentile¼ 6.8. (G) Percentage of control or SU5402-treated embryos (class I and class II) showing normal or abnormal AVE migration in
control (n¼ 4) or SU5402-treated embryos (n¼ 11) (χ2 test, **p¼ 0.0042).
F. Antonica et al. Developmental Biology 450 (2019) 132–140(Bae et al., 2012; Kubota and Ito, 2000). Although it is difﬁcult to rule out
this possibility, the fact that Brachyuryþ cells were speciﬁed and un-
derwent migration in treated embryos, as previously discussed, seems to
suggest that FGF signalling was functional post-implantation and that
FGFR inhibition had its impact primarily on cell division.
Taken together, our ﬁndings reveal that FGF signalling, known to be138involved in EPI/PE segregation, also facilitates coordination of the cell
cycle within PE progenitors. Moreover, we have demonstrated that co-
ordinated cell division contributes to tissue remodelling and cell move-
ments necessary for AVE migration. To our knowledge, this is the ﬁrst
study showing the requirement for FGF-mediated coordinated cell cycle
progression in PE cells for proper AVE migration and for morphogenetic
F. Antonica et al. Developmental Biology 450 (2019) 132–140events in mouse post-implantation embryos.
4. Materials and methods
4.1. Animals
This research has been regulated under the Animals (Scientiﬁc Pro-
cedures) Act 1986 Amendment Regulations 2012 following ethical re-
view by the University of Cambridge Animal Welfare and Ethical Review
Body (AWERB). The following mouse lines were used for the study:
R26Fucci2a (Mort et al., 2014), Cerl-GFP (Mesnard et al., 2004), F1
(C57BL/6 CBA).4.2. Embryo recovery and culture
Pre-implantation embryos (E3.5 – E4.75) were ﬂushed out from the
uteri as described in Bedzhov et al., 2014). E3.5 embryos were cultured
in drops of KSOM (Millipore, MR-020P) supplemented with SU-5402
10 μM (Abcam, ab146602) for 5 h and then KSOM only for 19 h. Con-
trol embryos were cultured in KSOM supplemented with 0.1% DMSO
(Sigma, D2650). Post-implantation embryos (E5.0 - E5.25 - E5.5) were
dissected at room temperature in M2 medium and then transferred in
IVC2 medium (Bedzhov et al., 2014). Pharmacological perturbation of
cell cycle was performed culturing early E5.5 embryos in IVC2 supple-
mented with the G2/M inhibitor RO-3306 10 μM (Sigma, SML0569).
Embryos were live imaged on glass bottom dishes (MatTek Corporation,
P35G-1.5-14-C). Embryos were cultured at 37 C in 5% CO2.4.3. Imaging
Embryos were live imaged using a Leica SP8 Multi-photon confocal
microscope. The wavelengths for confocal excitation were 514 nm laser
(for mVenus of R26Fucci2a), 488 nm (for CerI-GFP) while for multi-
photon excitation 1040 nm was used for R26Fucci2a embryos (when
double-transgenic embryos R26Fucci2a/CerI-GFP embryos imaged).
Fixed embryos were imaged on either Leica SP5 or SP8 confocal
microscopes.4.4. Immunostaining and EdU labelling
Embryos were ﬁxed in 4% paraformaldehyde for 20 min at room
temperature and permeabilized with 0.3% Triton X-100/0.1MGlycine in
PBS for 20 (pre-implantation) or 30 (post-implantation) min at room
temperature. The primary antibodies were added to the Antibody solu-
tion (0.1% Tween-20/10% ﬁltered FCS in PBS) and samples were incu-
bated at 4 C overnight. Embryos were then incubated for 2 h at room
temperature with secondary antibodies in Antibody solution. All washes
were done in PBST (PBS þ 0.1% Tween-20). DAPI was used as a nuclear
counterstain. EdU labelling was performed before ﬁxation by culturing
E3.5 embryos in KSOM supplemented with EdU 10 μM for 20 min. EdU
detection was performed in according to manufacturer instructions
(Thermo Fisher Scientiﬁc, C10339). Primary antibodies used: anti-Sox17
(R&D system, af1924), anti-Gata4, anti-Nanog (Abcam, ab80892), anti-
Oct4 (Santa Cruz, sc-5279), anti-phospho-Histone-H3 (Millipore, 06-
570), anti-Brachyury (R&D system, AF2085).4.5. Image processing and statistical analysis
Fiji software was used for image processing and Graphpad prism was
used for graph design and statistical analysis.
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